跳至主要内容
临床试验/ISRCTN22626706
ISRCTN22626706进行中(未招募)Unknown

A feasibility study: The efficacy and safety of heat applied to closed eyelids in enhancing the delivery of ocular hypotensive eye drops in the treatment of primary open-angle glaucoma

orth West Anglia NHS Foundation Trust0 个研究点目标入组 24 人开始时间: 2023年9月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Informed consent signed and dated
  • 2. Patients diagnosed with bilateral primary open-angle glaucoma (POAG) or ocular hypertension (OHT)
  • 3. Patient aged =18 years old
  • 4. Both eyes with a central corneal thickness of between 500-600 µm
  • 5. Both eyes with a diagnosis of POAG or OHT, initially treated and controlled for at least six months by a prostaglandin analogue monotherapy (mane instillation)
  • 6. IOP = 24 mmHg in at least one eye POAG
  • 7. IOP = 30 mmHg in at least one eye OHT

排除标准

  • 1. Fundus examination not performed or not available within 12 months
  • 2. Visual field not performed or not available within 12 months
  • 3. Advanced stage of glaucoma, defined by at least one of the following criteria:
  • 4. Absolute defect in the ten degrees central point of the visual fields
  • 5. Severe visual field loss: MD < -18 dB
  • 6. Risk of visual field worsening as a consequence of participation in the study according to the investigator’s best judgment
  • 7. Far best corrected visual acuity = +0.7 logMAR
  • 8. History of trauma, infection, clinically significant inflammation within the previous three months
  • 9. Ongoing or known history of ocular allergy and/or uveitis and/or viral infection
  • 10. Clinically significant or progressive retinal disease (e.g. retinal degeneration, diabetic retinopathy, retinal detachment)
  • 11. Conjunctival hyperaemia (Grade 5 - Efron scale)
  • 12. Superficial punctate keratitis (Grade 4/5 – Oxford scale)
  • 13. Blepharitis (Grade 3 – Efron scale)
  • 14. Severe dry eye as assessed by the investigator
  • 15. Corneal ulceration
  • 16. Any palpebral abnormality incompatible with a good examination
  • 17. Any other abnormality preventing accurate assessment e.g. reliable tonometry measurement, visual field examination, fundus examination.
  • 18. A patient judged to have poor compliance with their glaucoma drops according to the investigator’s best judgement

研究者

发起方
orth West Anglia NHS Foundation Trust

相似试验